Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.9000
+0.1752 (24.17%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Sutro Biopharma Employees
Sutro Biopharma had 310 employees as of December 31, 2024. The number of employees increased by 8 or 2.65% compared to the previous year.
Employees
310
Change (1Y)
8
Growth (1Y)
2.65%
Revenue / Employee
$200,139
Profits / Employee
-$733,745
Market Cap
75.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
STRO News
- 5 weeks ago - Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025 - GlobeNewsWire
- 5 weeks ago - Penny Stock Sutro Biopharma Cuts Costs, Refocuses Pipeline - Benzinga
- 5 weeks ago - Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights - GlobeNewsWire
- 5 weeks ago - Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline - GlobeNewsWire
- 7 weeks ago - Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Sutro Biopharma: I Don't Buy That Their Pipeline Is Worthless - Seeking Alpha
- 5 months ago - Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire